Thromboelastography in Non-elective Cesarean Delivery
|ClinicalTrials.gov Identifier: NCT01514591|
Recruitment Status : Completed
First Posted : January 23, 2012
Last Update Posted : June 21, 2013
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||33 participants|
|Official Title:||Thromboelastography to Assess Hemostatic Changes in Laboring Patients Undergoing Non-elective (Intrapartum) Cesarean Delivery|
|Study Start Date :||August 2011|
|Actual Primary Completion Date :||June 2013|
|Actual Study Completion Date :||June 2013|
Non-elective Cesarean Delivery
We will only enroll patients undergoing non-elective CS with an 'epidural top-up' for surgical anesthesia. By definition, our study will only apply to laboring women with working labor epidurals (which were provided for labor analgesia).
- Estimated blood loss; Coagulation data (Thromboelastography, Laboratory) [ Time Frame: pre and post cesarean delivery, an expected average of 75 minutes ]This study will allow us to collect more information about the hemostatic effects that occur during non-elective Cesarean delivery. This information will add to current knowledge base (which we have published) about coagulation changes in the peripartum period in patients undergoing non-elective Cesarean section.
- Hematologic indices [ Time Frame: Pre and post cesarean delivery, an expected average of 75 minutes ]Hematologic indices will include: Hemoglobin concentration and platelet count.
Biospecimen Retention: Samples With DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01514591
|United States, California|
|Lucile Packard Children's Hospital|
|Stanford, California, United States, 94305|
|Principal Investigator:||Alex Butwick, MBBS, FRCA||Stanford University|